This compound is a peptide synthesis intermediate featuring a fluorenylmethoxycarbonyl (Fmoc) protecting group and a dihydroorotamide-modified phenylalanine residue. It is primarily used in the research and manufacturing of specialized peptides.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1253282-31-3
Fmoc-D-Arg-OH
Peptide synthesis intermediate
L-Ornithine, N2-[(1,1-dimethylethoxy)carbonyl]-N5-[imino[[(4-methylphenyl)sulfonyl]amino]methyl]-
Peptide synthesis intermediate
Boc-His(Trt)-Gly-OH
Peptide synthesis intermediate
Fmoc-His-Aib-OH
Peptide synthesis intermediate
(S)-1,1,1-trifluoropropan-2-amine hydrochloride
Pharmaceutical intermediate
3-Methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)aniline
pharmaceutical intermediate
Benzyl 4-(oxetan-3-yl) piperazine-1-carboxylate
Pharmaceutical intermediate for drug synthesis
Benzamide, N-(1,2-dihydro-1-(6-(hydroxymethyl)-4-(triphenylmethyl)-2-morpholinyl)-2-oxo-4-pyrimidinyl)-, (2R-cis)-
Morpholino cytosine monomer intermediate
(2S)-3-[4-[[(4S)-2,6-dioxo-1,3-diazinane-4-carbonyl]amino]phenyl]-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid
TYZSMQUWFLKJFB-ZEQRLZLVSA-N
C1[C@H](NC(=O)NC1=O)C(=O)NC2=CC=C(C=C2)C[C@@H](C(=O)O)NC(=O)OCC3C4=CC=CC=C4C5=CC=CC=C35